Laura Bukavina (@laurabukavinamd) 's Twitter Profile
Laura Bukavina

@laurabukavinamd

Uro Onc- Translational Research Lead GU ONC @CleClinicUro 🔬 bladder microbiome🧫🧪 ImmunoOnc @drexelmedicine @JohnsHopkinsSPH 🇺🇦@EUplatinum associate editor

ID: 2786427392

linkhttps://www.lerner.ccf.org/immunotherapy/bukavina/ calendar_today02-09-2014 18:09:32

5,5K Tweet

6,6K Takipçi

1,1K Takip Edilen

Laura Bukavina (@laurabukavinamd) 's Twitter Profile Photo
Laura Bukavina
@laurabukavinamd

a year ago

The NTACT residual disease test, eloquently presented by @scientistatlrge published in JCO Precision Oncology. .Remarkably, over 50% of patients without visible residual disease had positive mutations, indicative of field cancerization—mutations present in adjacent normal tissue WITHOUT

The NTACT residual disease test, eloquently presented by @scientistatlrge published in <a href="/JCOPO_ASCO/">JCO Precision Oncology</a>. .Remarkably, over 50% of patients without visible residual disease had positive mutations, indicative of field cancerization—mutations present in adjacent normal tissue WITHOUT